{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:12:58Z","timestamp":1648609978759},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T00:00:00Z","timestamp":1494460800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mater Sci: Mater Med"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1007\/s10856-017-5900-0","type":"journal-article","created":{"date-parts":[[2017,5,11]],"date-time":"2017-05-11T15:00:12Z","timestamp":1494514812000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Design and characterization of lisinopril-loaded superparamagnetic nanoparticles as a new contrast agent for in vitro, in vivo MRI imaging, diagnose the tumors and drug delivery system"],"prefix":"10.1007","volume":"28","author":[{"given":"Sajjad","family":"Abbasi Pour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Shaterian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,5,11]]},"reference":[{"key":"5900_CR1","doi-asserted-by":"crossref","first-page":"8355","DOI":"10.1021\/ic061262q","volume":"45","author":"VC Pierre","year":"2006","unstructured":"Pierre VC, Botta M, Aime S, Raymond KN. Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules1. Inorg Chem. 2006;45:8355\u201364.","journal-title":"Inorg Chem"},{"key":"5900_CR2","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1021\/ja0765363","volume":"130","author":"A Datta","year":"2008","unstructured":"Datta A, Hooker JM, Botta M, Francis MB, Aime S, Raymond KN. High relaxivity gadolinium hydroxypyridonate-viral capsid conjugates: nanosized MRI contrast agents1. J Am Chem Soc. 2008;130:2546\u201352.","journal-title":"J Am Chem Soc"},{"key":"5900_CR3","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1039\/C5NR00774G","volume":"7","author":"L Yang","year":"2015","unstructured":"Yang L, Zhou Z, Liu H, Wu C, Zhang H, Huang G, et al. Europium-engineered iron oxide nanocubes with high T1 and T2 contrast abilities for MRI in living subjects. Nanoscale. 2015;7:6843\u201350.","journal-title":"Nanoscale"},{"key":"5900_CR4","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1016\/j.biomaterials.2011.03.018","volume":"32","author":"H Yang","year":"2011","unstructured":"Yang H, Zhuang Y, Sun Y, Dai A, Shi X, Wu D, et al. Targeted dual-contrast T1-and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles. Biomaterials. 2011;32:4584\u201393.","journal-title":"Biomaterials"},{"key":"5900_CR5","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1021\/nn900761s","volume":"3","author":"JY Park","year":"2009","unstructured":"Park JY, Baek MJ, Choi ES, Woo S, Kim JH, Kim TJ, et al. Paramagnetic ultrasmall gadolinium oxide nanoparticles as advanced T1 MRI contrast agent: account for large longitudinal relaxivity, optimal particle diameter, and in vivo T1 MR images. ACS Nano. 2009;3:3663\u20139.","journal-title":"ACS Nano"},{"key":"5900_CR6","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1039\/C3NR04691E","volume":"6","author":"G Huang","year":"2014","unstructured":"Huang G, Hu J, Zhang H, Zhou Z, Chi X, Gao J. Highly magnetic iron carbide nanoparticles as effective T2 contrast agents. Nanoscale. 2014;6:726\u201330.","journal-title":"Nanoscale"},{"key":"5900_CR7","doi-asserted-by":"crossref","first-page":"7816","DOI":"10.1039\/c3cs60149h","volume":"42","author":"J Gallo","year":"2013","unstructured":"Gallo J, Long NJ, Aboagye EO. Magnetic nanoparticles as contrast agents in the diagnosis and treatment of cancer. Chem Soc Rev. 2013;42:7816\u201333.","journal-title":"Chem Soc Rev"},{"key":"5900_CR8","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nm1467","volume":"13","author":"J-H Lee","year":"2007","unstructured":"Lee J-H, Huh Y-M, Jun Y-W, Seo J-W, Jang J-T, Song H-T, et al. Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat Med. 2007;13:95\u20139.","journal-title":"Nat Med"},{"key":"5900_CR9","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1039\/c3nr05550g","volume":"6","author":"G Wang","year":"2014","unstructured":"Wang G, Zhang X, Skallberg A, Liu Y, Hu Z, Mei X, et al. One-step synthesis of water-dispersible ultra-small Fe3O4 nanoparticles as contrast agents for T1 and T2 magnetic resonance imaging. Nanoscale. 2014;6:2953\u201363.","journal-title":"Nanoscale"},{"key":"5900_CR10","doi-asserted-by":"crossref","first-page":"3995","DOI":"10.1016\/j.biomaterials.2004.10.012","volume":"26","author":"AK Gupta","year":"2005","unstructured":"Gupta AK, Gupta M. Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005;26:3995\u20134021.","journal-title":"Biomaterials"},{"key":"5900_CR11","unstructured":"Schwertmann U, Cornell RM. Iron oxides in the laboratory: Preparation and Characterization, Second, Completely Revised and Extended Edition, WILEY-VCH Verlag GmbH, D-69469 Weinheim (Federal Republic of Germany), 2000."},{"key":"5900_CR12","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1039\/c1nr10173k","volume":"3","author":"E Amstad","year":"2011","unstructured":"Amstad E, Textor M, Reimhult E. Stabilization and functionalization of iron oxide nanoparticles for biomedical applications. Nanoscale. 2011;3:2819\u201343.","journal-title":"Nanoscale"},{"key":"5900_CR13","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1021\/cr9003538","volume":"110","author":"A Louie","year":"2010","unstructured":"Louie A. Multimodality imaging probes: design and challenges. Chem Rev. 2010;110:3146\u201395.","journal-title":"Chem Rev"},{"key":"5900_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/smll.200700595","volume":"4","author":"N Lewinski","year":"2008","unstructured":"Lewinski N, Colvin V, Drezek R. Cytotoxicity of nanoparticles. Small. 2008;4:26\u201349.","journal-title":"Small"},{"key":"5900_CR15","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mrm.1910260104","volume":"26","author":"W Bauer","year":"1992","unstructured":"Bauer W, Schculten K. Theory of contrast agents in magnetic resonance imaging: coupling of spin relaxation and transport. Magn Reson Med. 1992;26:16\u201339.","journal-title":"Magn Reson Med"},{"key":"5900_CR16","doi-asserted-by":"crossref","unstructured":"Kraft EC, Trenkwalder C, Auer DP. T2*-weighted MRI differentiates multiple system atrophy from Parkinson\u2019s disease, Neurology, 2002;59:1265\u201367.","DOI":"10.1212\/01.WNL.0000032757.66992.3C"},{"key":"5900_CR17","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1148\/rg.295095034","volume":"29","author":"GB Chavhan","year":"2009","unstructured":"Chavhan GB, Babyn PS, Thomas B, Shroff MM, Haacke EM. Principles, techniques, and applications of T2*-based MR imaging and its special applications. Radiographics. 2009;29:1433\u201349.","journal-title":"Radiographics"},{"key":"5900_CR18","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/adma.200802366","volume":"21","author":"HB Na","year":"2009","unstructured":"Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater. 2009;21:2133\u201348.","journal-title":"Adv Mater"},{"key":"5900_CR19","doi-asserted-by":"crossref","first-page":"7741","DOI":"10.1073\/pnas.86.20.7741","volume":"86","author":"M Ehlers","year":"1989","unstructured":"Ehlers M, Fox EA, Strydom DJ, Riordan JF. Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme. Proc Natl Acad Sci. 1989;86:7741\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"5900_CR20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pestbp.2010.11.006","volume":"99","author":"J Pourahmad","year":"2011","unstructured":"Pourahmad J, Hosseini M-J, Bakan S, Ghazi-Khansari M. Hepatoprotective activity of angiotensin-converting enzyme (ACE) inhibitors, captopril and enalapril, against paraquat toxicity. Pest Biochem Physiol. 2011;99:105\u201310.","journal-title":"Pest Biochem Physiol"},{"key":"5900_CR21","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/106002808802200501","volume":"22","author":"G Armayor","year":"1988","unstructured":"Armayor G, Lopez L. Lisinopril: a new angiotensin-converting enzyme inhibitor. Drug Intell Clin Pharm. 1988;22:365\u201372.","journal-title":"Drug Intell Clin Pharm"},{"key":"5900_CR22","doi-asserted-by":"crossref","first-page":"10398","DOI":"10.1021\/la301694q","volume":"28","author":"WE Ghann","year":"2012","unstructured":"Ghann WE, Aras O, Fleiter T, Daniel M-C. Syntheses and characterization of lisinopril-coated gold nanoparticles as highly stable targeted CT contrast agents in cardiovascular diseases. Langmuir. 2012;28:10398\u2013408.","journal-title":"Langmuir"},{"key":"5900_CR23","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1039\/a902652e","volume":"9","author":"ZA Bao","year":"1999","unstructured":"Bao ZA, Rogers JE, Katz H. Printable organic and polymeric semiconducting materials and devices. J Mate Chem. 1999;9:1895\u2013904.","journal-title":"J Mate Chem"},{"key":"5900_CR24","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1021\/cm9900305","volume":"11","author":"BZ Tang","year":"1999","unstructured":"Tang BZ, Geng Y, Lam JWY, Li B. Processible nanostructured materials with electrical conductivity and magnetic susceptibility: preparation and properties of maghemite\/polyaniline nanocomposite films. Chem Mater. 1999;11:1581\u20139.","journal-title":"Chem Mater"},{"key":"5900_CR25","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1021\/la702887m","volume":"24","author":"KM Ho","year":"2008","unstructured":"Ho KM, Li P. Design and synthesis of novel magnetic core-shell polymeric particles. Langmuir. 2008;24:1801\u20137.","journal-title":"Langmuir"},{"key":"5900_CR26","doi-asserted-by":"crossref","first-page":"15797","DOI":"10.1039\/c4ra01124d","volume":"4","author":"S Sobhani","year":"2014","unstructured":"Sobhani S, Falatooni ZM, Honarmand M. Synthesis of phosphoric acid supported on magnetic core\u2013shell nanoparticles: a novel recyclable heterogeneous catalyst for Kabachnik\u2013Fields reaction in water. RSC Adv. 2014;4:15797\u2013806.","journal-title":"RSC Adv"},{"key":"5900_CR27","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1039\/c3ra46437g","volume":"4","author":"K Azizi","year":"2014","unstructured":"Azizi K, Heydari A. Vitamin B1 supported on silica-encapsulated \u0263-Fe2O3 nanoparticles: design, characterization and application as a greener biocatalyst for highly efficient acylation. RSC Adv. 2014;4:8812\u20136.","journal-title":"RSC Adv"},{"key":"5900_CR28","unstructured":"Altaf M, Imran A, Sholapur H. Gastric-mucoadhesivedrdg delivery systems of captopril. J App Pharm 2011;4:346\u2013358."},{"key":"5900_CR29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1148\/rg.262055063","volume":"26","author":"R Bitar","year":"2006","unstructured":"Bitar R, Leung G, Perng R, Tadros S, Moody AR, Sarrazin J, et al. MR pulse sequences: what every radiologist wants to know but is afraid to ask. Radiographics. 2006;26:513\u201337.","journal-title":"Radiographics"},{"key":"5900_CR30","first-page":"223","volume":"2","author":"M Khalkhali","year":"2015","unstructured":"Khalkhali M, Sadighian S, Rostamizadeh K, Khoeini F, Naghibi M, Hamidi M. Simultaneous diagnosis and drug delivery by silymarin-loaded magnetic nanoparticles. Nanomed J. 2015;2:223\u201330.","journal-title":"J Nanomed Nanotechnol Biol Med"},{"key":"5900_CR31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3144\/expresspolymlett.2010.42","volume":"4","author":"N Arsalani","year":"2010","unstructured":"Arsalani N, Fattahi H, Nazarpoor M. Synthesis and characterization of PVP-functionalized superparamagnetic Fe3O4 nanoparticles as an MRI contrast agent. Express Polym Lett. 2010;4:329\u201338.","journal-title":"Express Polym Lett"},{"key":"5900_CR32","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1039\/C1CS15248C","volume":"41","author":"N Lee","year":"2012","unstructured":"Lee N, Hyeon T. Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev. 2012;41:2575\u201389.","journal-title":"Chem Soc Rev"},{"key":"5900_CR33","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.colsurfb.2015.03.021","volume":"129","author":"N Sattarahmady","year":"2015","unstructured":"Sattarahmady N, Zare T, Mehdizadeh A, Azarpira N, Heidari M, Lotfi M, et al. Dextrin-coated zinc substituted cobalt-ferrite nanoparticles as an MRI contrast agent: in vitro and in vivo imaging studies. Coll Surf B. 2015;129:15\u201320.","journal-title":"Coll Surf B"},{"key":"5900_CR34","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/mrm.21744","volume":"60","author":"T He","year":"2008","unstructured":"He T, Gatehouse PD, Smith GC, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurements in iron\u2010overloaded thalassemia: an in vivo study to investigate optimal methods of quantification. Magn Reson Med. 2008;60:1082\u20139.","journal-title":"Magn Reson Med"},{"key":"5900_CR35","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/mrm.21625","volume":"60","author":"T He","year":"2008","unstructured":"He T, Gatehouse PD, Kirk P, Mohiaddin RH, Pennell DJ, Firmin DN. Myocardial T2* measurement in iron\u2010overloaded thalassemia: an ex vivo study to investigate optimal methods of quantification. Magn Reson Med. 2008;60:350\u20136.","journal-title":"Magn Reson Med"},{"key":"5900_CR36","doi-asserted-by":"crossref","first-page":"6805","DOI":"10.1021\/nn101670k","volume":"4","author":"X Yang","year":"2010","unstructured":"Yang X, Grailer JJ, Rowland IJ, Javadi A, Hurley SA, Matson VZ. Multifunctional stable and pH-responsive polymer vesicles formed by heterofunctional triblock copolymer for targeted anticancer drug delivery and ultrasensitive MR imaging. ACS Nano. 2010;4:6805\u201317.","journal-title":"ACS Nano"},{"key":"5900_CR37","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/nn406158h","volume":"8","author":"R Roosbroeck Van","year":"2014","unstructured":"Van Roosbroeck R, Van Roy W, Stakenborg T, Trekker J, Hollander AD, Dresselaers T. Synthetic antiferromagnetic nanoparticles as potential contrast agents in MRI. ACS Nano. 2014;8:2269\u201378.","journal-title":"ACS Nano"},{"key":"5900_CR38","first-page":"1727","volume":"10","author":"J Estelrich","year":"2015","unstructured":"Estelrich J, S\u00e1nchez-Mart\u00edn MJ, Busquets MA. Nanoparticles in magnetic resonance imaging: from simple to dual contrast agents. Int J Nanomedicine. 2015;10:1727\u201335.","journal-title":"Int J Nanomedicine"},{"key":"5900_CR39","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.apsusc.2015.08.140","volume":"356","author":"S Sitthichai","year":"2015","unstructured":"Sitthichai S, Pilapong C, Thongtem T, Thongtem S. CMC-coated Fe3O4 nanoparticles as new MRI probes for hepatocellular carcinoma. Appl Surf Sci. 2015;356:972\u20137.","journal-title":"Appl Surf Sci"}],"container-title":["Journal of Materials Science: Materials in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10856-017-5900-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-017-5900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10856-017-5900-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,24]],"date-time":"2019-09-24T11:29:23Z","timestamp":1569324563000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10856-017-5900-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["5900"],"URL":"https:\/\/doi.org\/10.1007\/s10856-017-5900-0","relation":{},"ISSN":["0957-4530","1573-4838"],"issn-type":[{"value":"0957-4530","type":"print"},{"value":"1573-4838","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,5,11]]},"article-number":"91"}}